Tuncay KÜME, Korcan DEMİR, Ece BÖBER, Ayhan ABACI, Ahu PAKETÇİ, Sezer ACAR, Özlem GÜRSOY ÇALAN

Positive correlation of galanin with insulin resistance and triglyceride levels in obese children

Background/aim: Galanin is a neuropeptide that is shown to be involved in the regulation of food intake and glucose homeostasis. Theobjective of this study was to evaluate the relation of serum galanin levels with anthropometric and metabolic parameters in obese andhealthy children.Material and methods: The cross-sectional study consisted of 38 obese children (mean age: 11.9 ± 3.0 years) and 30 healthy children(mean age: 11.4 ± 2.0 years). Clinical and biochemical parameters [glucose, insulin, homeostasis model assessment-insulin resistance(HOMA-IR), lipids, galanin, and leptin levels] were assessed.Results: Serum galanin and leptin levels were significantly higher in obese children. In obese children, galanin levels were positivelycorrelated with fasting glucose (r = 0.398, p = 0.013), insulin (r = 0.383, p = 0.018), HOMA-IR (r = 0.375, p = 0.020), and triglycerides(r = 0.391, p=0.015). Multivariate backward regression analysis revealed that galanin levels were significantly associated with fastingglucose, insulin, HOMA-IR, and triglyceride, which explained 42.0% of the variance (r2 = 0.483, P < 0.001).Conclusions: Serum galanin levels were significantly higher in obese children than healthy controls and positively correlated withinsulin resistance and triglycerides in obese children. This study suggests that galanin is associated with glucose homeostasis and lipidmetabolism in childhood obesity.

PDF

___

Tan BK, Hallschmid M, Kern W, Lehnert H, Randeva HS. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J Clin Endocrinol Metab 2011; 96: 669-673.
Mishra AK, Dubey V, Ghosh AR. Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota. Metabolism 2016; 65: 48-65.
Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology 2007; 132: 2116-2130.
Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 1983; 164: 124-128.
Fang P, Yu M, Shi M, Zhang Z, Sui Y, Guo L, Bo P. Galanin peptide family as a modulating target for contribution to metabolic syndrome. Gen Comp Endocrinol 2012; 179: 115- 120.
Fang P, Yu M, Guo L, Bo P, Zhang Z, Shi M. Galanin and its receptors: a novel strategy for appetite control and obesity therapy. Peptides 2012; 36: 331-339.
Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF. Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide’s effects in the brain. Peptides 1990; 11: 995-1001.
Poritsanos NJ, Mizuno TM, Lautatzis ME, Vrontakis M. Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. Int J Obes (Lond) 2009; 33: 1381-1389.
Tempel DL, Leibowitz KJ, Leibowitz SF. Effects of PVN galanin on macronutrient selection. Peptides 1988; 9: 309-314.
Adams AC, Clapham JC, Wynick D, Speakman JR. Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference. J Neuroendocrinol 2008; 20: 199- 206.
Corwin RL, Robinson JK, Crawley JN. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. Eur J Neurosci 1993; 5: 1528-1533.
Baranowska B, Wasilewska-Dziubinska E, Radzikowska M, Plonowski A, Roguski K. Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa. Metabolism 1997; 46: 1384-1389.
Fang P, Bo P, Shi M, Yu M, Zhang Z. Circulating galanin levels are increased in patients with gestational diabetes mellitus. Clin Biochem 2013; 46: 831-833.
Legakis I, Mantzouridis T, Mountokalakis T. Positive correlation of galanin with glucose in type 2 diabetes. Diabetes Care 2005;28:759-760.
Zhang Z, Gu C, Fang P, Shi M, Wang Y, Peng Y, Bo P, Zhu Y. Endogenous galanin as a novel biomarker to predict gestational diabetes mellitus. Peptides 2014; 54: 186-9.
Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Roguski K, Borowiec M. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes Obes Metab 2000; 2: 99-103.
Cansu A, Serdaroglu A, Camurdan O, Hirfanoglu T, Cinaz P. Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate. Horm Res Paediatr 2011; 76: 65-71.
Celi F, Bini V, Papi F, Santilli E, Ferretti A, Mencacci M, Berioli MG, De Giorgi G, Falorni A. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development. Clin Endocrinol (Oxf) 2005; 63: 139-45.
Fang P, Yu M, Gu X, Shi M, Zhu Y, Zhang Z, Bo P. Low levels of plasma galanin in obese subjects with hypertension. J Endocrinol Invest 2017; 40: 63-8.
Sandoval-Alzate HF, Agudelo-Zapata Y, González-Clavijo AM, Poveda NE, Espinel-Pachón CF, Escamilla-Castro JA, Márquez- Julio HL, Alvarado-Quintero H, Rojas-Rodríguez FG, Arteaga- Díaz JM et al. Serum galanin levels in young healthy lean and obese non-diabetic men during an oral glucose tolerance test. Sci Rep 2016; 6: 31661.
Demir K, Ozen S, Konakci E, Aydin M, Darendeliler F. A comprehensive online calculator for pediatric endocrinologists: CEDD Cozum/TPEDS Metrics. J Clin Res Pediatr Endocrinol 2017; 9: 182-184.
Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002: 1-190.
World Health Organization. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. Technical Report Series No. 854. Geneva, Switzerland: WHO; 1995.
Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur J Pediatr 2008; 167: 383- 389.
Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170-179.
Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, Riccardi G, Rubba P. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006; 16: 279-284.
Meczekalski B, Warenik-Szymankiewicz A. The role of galanin in the etiology of obesity in young girls. Ginekol Pol 1999; 70: 328-332.
He B, Shi M, Zhang L, Li G, Zhang L, Shao H, Li J, Fang P, Ma Y, Shi Q et al. Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats. Physiol Behav 2011; 103: 284- 289.
Ahren B, Pacini G, Wynick D, Wierup N, Sundler F. Lossof- function mutation of the galanin gene is associated with perturbed islet function in mice. Endocrinology 2004; 145: 3190-3196.
Guo L, Shi M, Zhang L, Li G, Zhang L, Shao H, Sui Y. Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats. Gen Comp Endocrinol 2011; 173: 159-163.
Liang Y, Sheng S, Fang P, Ma Y, Li J, Shi Q, Sui Y, Shi M. Exerciseinduced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats. Pharmacol Biochem Behav 2012; 100: 554-559.
Zorrilla EP, Brennan M, Sabino V, Lu X, Bartfai T. Galanin type 1 receptor knockout mice show altered responses to high-fat diet and glucose challenge. Physiol Behav 2007; 91: 479-485.
Bu L, Yao Q, Liu Z, Tang W, Zou J, Qu S. Combined galanin with insulin improves insulin sensitivity of diabetic rat muscles. J Endocrinol 2014; 221: 157-165.
Augustin R. The protein family of glucose transport facilitators: It’s not only about glucose after all. IUBMB Life 2010; 62: 315- 333.
Fang P, Shi M, Zhu Y, Bo P, Zhang Z. Type 2 diabetes mellitus as a disorder of galanin resistance. Exp Gerontol 2016; 73: 72-77.
Barson JR, Karatayev O, Gaysinskaya V, Chang GQ, Leibowitz SF. Effect of dietary fatty acid composition on food intake, triglycerides, and hypothalamic peptides. Regul Pept 2012; 173: 13-20.
Crawley JN, Austin MC, Fiske SM, Martin B, Consolo S, Berthold M, Langel U, Fisone G, Bartfai T. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J Neurosci 1990; 10: 3695-3700.
Fang P, Yu M, Gu X, Shi M, Zhu Y, Zhang Z, Bo P. Circulating galanin and galanin like peptide concentrations are correlated with increased triglyceride concentration in obese patients. Clin Chim Acta 2016; 461: 126-129.
Plaisier CL, Kyttala M, Weissglas-Volkov D, Sinsheimer JS, Huertas-Vazquez A, Riba L, Ramírez-Jimenez S, de Bruin TW, Tusie-Luna T, Aouizerat BE et al. Galanin preproprotein is associated with elevated plasma triglycerides. Arterioscler Thromb Vasc Biol 2009; 29: 147-152.
Leibowitz SF, Dourmashkin JT, Chang GQ, Hill JO, Gayles EC, Fried SK, Wang J. Acute high-fat diet paradigms link galanin to triglycerides and their transport and metabolism in muscle. Brain Res 2004; 1008: 168-178.
Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770.
Cheung CC, Hohmann JG, Clifton DK, Steiner RA. Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus. Neuroscience 2001; 103: 423-432.
Sahu A. Evidence suggesting that galanin (GAL), melaninconcentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinology 1998; 139: 795-798.
Sahu A. Leptin decreases food intake induced by melaninconcentrating hormone (MCH), galanin (GAL) and neuropeptide Y (NPY) in the rat. Endocrinology 1998; 139: 4739-4742.
Hohmann JG, Teklemichael DN, Weinshenker D, Wynick D, Clifton DK, Steiner RA. Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin. Mol Cell Biol 2004; 24: 2978-2985.
Laque A, Yu S, Qualls-Creekmore E, Gettys S, Schwartzenburg C, Bui K, Rhodes C, Berthoud HR, Morrison CD, Richards BK et al. Leptin modulates nutrient reward via inhibitory galanin action on orexin neurons. Mol Metab 2015; 4: 706-717.
Henderson M, Rabasa-Lhoret R, Bastard JP, Chiasson JL, Baillargeon JP, Hanley JA, Lambert M. Measuring insulin sensitivity in youth: how do the different indices compare with the gold-standard method? Diabetes Metab 2011; 37: 72-78.